MDT icon

Medtronic

94.03 USD
-0.22
0.23%
At close Updated Sep 12, 4:00 PM EDT
Pre-market
After hours
94.01
-0.02
0.02%
1 day
-0.23%
5 days
2.03%
1 month
2.12%
3 months
6.26%
6 months
2.75%
Year to date
17.22%
1 year
4.48%
5 years
-12.1%
10 years
36.81%
 

About: One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.

Employees: 95,000

0
Funds holding %
of 7,462 funds
0
Analysts bullish %
of 11 analysts

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

19% more call options, than puts

Call options by funds: $1.02B | Put options by funds: $860M

1.37% more ownership

Funds ownership: 82.88% [Q1] → 84.25% (+1.37%) [Q2]

2% more repeat investments, than reductions

Existing positions increased: 869 | Existing positions reduced: 855

3% less first-time investments, than exits

New positions opened: 144 | Existing positions closed: 148

3% less capital invested

Capital invested by funds: $97B [Q1] → $94B (-$2.96B) [Q2]

2% less funds holding

Funds holding: 2,143 [Q1] → 2,102 (-41) [Q2]

28% less funds holding in top 10

Funds holding in top 10: 43 [Q1] → 31 (-12) [Q2]

Research analyst outlook

11 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$95
1% upside
Avg. target
$102
9% upside
High target
$115
22% upside

11 analyst ratings

positive
73%
neutral
27%
negative
0%
Argus Research
David Toung
$115
Buy
Maintained
26 Aug 2025
Citigroup
Joanne Wuensch
$101
Buy
Maintained
21 Aug 2025
Truist Securities
Richard Newitter
$96
Hold
Maintained
21 Aug 2025
Wells Fargo
Larry Biegelsen
$100
Overweight
Maintained
20 Aug 2025
UBS
Danielle Antalffy
$95
Neutral
Maintained
20 Aug 2025

Financial journalist opinion

Based on 45 articles about MDT published over the past 30 days

Positive
The Motley Fool
22 hours ago
Billionaire Ken Griffin Piled Into These 2 Unstoppable Dividend Stocks During the Second Quarter
Ken Griffin is the founder and CEO of Citadel, a hedge fund established in 1990, whose long-term performance has been excellent. Citadel's track record suggests that Griffin knows a thing or two about how to beat the market, so it's not a bad idea to look into the fund's portfolio to get some ideas.
Billionaire Ken Griffin Piled Into These 2 Unstoppable Dividend Stocks During the Second Quarter
Neutral
Seeking Alpha
3 days ago
Medtronic Plc (MDT) Presents At Deutsche Bank Healthcare Summit Transcript
Medtronic plc (NYSE:MDT ) Deutsche Bank Healthcare Summit September 10, 2025 12:00 PM EDT Company Participants Conference Call Participants Pito Chickering - Deutsche Bank AG, Research Division Presentation Pito Chickering Research Analyst All right. Good afternoon.
Medtronic Plc (MDT) Presents At Deutsche Bank Healthcare Summit Transcript
Neutral
Seeking Alpha
5 days ago
Medtronic Plc (MDT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Medtronic plc (NYSE:MDT ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 4:50 PM EDT Company Participants Thierry Pieton - Executive VP & CFO Conference Call Participants Patrick Wood - Morgan Stanley, Research Division Presentation Patrick Wood MD of Equity Research I think we'll kick things off. Thanks so much, everybody.
Medtronic Plc (MDT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Positive
Zacks Investment Research
8 days ago
MDT Stock May Benefit From New Regulatory Wins for Its MiniMed 780G
Medtronic secures FDA milestones for its MiniMed 780G system, expanding use to type 2 diabetes and enabling sensor integration.
MDT Stock May Benefit From New Regulatory Wins for Its MiniMed 780G
Positive
The Motley Fool
8 days ago
3 High-Yielding Dividend Stocks to Buy and Hold For the Long Haul
Dividend stocks that offer high yields can be gold mines for your portfolio as they can generate loads of recurring income for you for years. Whether you want to use the money to reinvest in those stocks or simply use the dividend income to help add to your cash position, they can make for great long-term investments to have.
3 High-Yielding Dividend Stocks to Buy and Hold For the Long Haul
Neutral
Seeking Alpha
9 days ago
Medtronic Plc (MDT) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)
Medtronic plc (NYSE:MDT ) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 8:00 AM EDT Company Participants Geoffrey Martha - Chairman of the Board & CEO Thierry Pieton - Executive VP & CFO Conference Call Participants Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Presentation Larry Biegelsen Senior Medical Device Equity Research Analyst Okay. Good morning.
Medtronic Plc (MDT) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)
Neutral
PRNewsWire
9 days ago
Study of Medtronic Hugo™ robotic-assisted surgery system in hernia repair meets safety and effectiveness endpoints
First-ever investigational device exemption clinical study for robotic-assisted hernia repair in the U.S. presented at the American Hernia Society annual meeting GALWAY, Ireland and NASHVILLE, Tenn. , Sept. 4, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced results from the Enable Hernia Repair clinical study evaluating the performance of the Hugo™ robotic-assisted surgery (RAS) system in inguinal and ventral hernia repair procedures.
Study of Medtronic Hugo™ robotic-assisted surgery system in hernia repair meets safety and effectiveness endpoints
Neutral
PRNewsWire
11 days ago
FDA Clears MiniMed™ 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes
GALWAY, Ireland , Sept. 2, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones that broaden the MiniMed™ 780G system portfolio: clearance of the SmartGuard™ algorithm as an interoperable automated glycemic controller (iAGC), enabling integration with the Instinct sensor, made by Abbott, for type 1 diabetes, and approval of the MiniMed™ 780G system for use in adults 18+ with insulin-requiring type 2 diabetes.
FDA Clears MiniMed™ 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes
Positive
The Motley Fool
15 days ago
3 Best Dividend Stocks to Buy Now
One of the highest honors among dividend stocks is to be a Dividend Aristocrat®, which requires 25 consecutive years or more in annual increases. The title Dividend Aristocrat is such a big deal that the term is a registered trademark of Standard & Poor's Financial Services LLC.
3 Best Dividend Stocks to Buy Now
Neutral
PRNewsWire
15 days ago
Medtronic executives to speak at upcoming investor conferences
GALWAY, Ireland , Aug. 29, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the following investor conferences: 2025 Wells Fargo Healthcare Conference Thursday, September 4, 2025, at 8:00 a.m. EDT (7:00 a.m.
Medtronic executives to speak at upcoming investor conferences
Charts implemented using Lightweight Charts™